Opinion: Led the Fed do its job, and let Powell finish his work leading it
By Kirk Lesh The question of whether Federal Reserve Chairman Jerome Powell’s term should be extended has received a lot of attention recently. It seems like The Washington Post, The New York Times or The Wall Street Journal has an article on this topic every week. In a similar vein, it seems someone from the Read More →
Olaplex shares jump 17% after $1.6B IPO
NOTE: This article was originally posted at 11:30 a.m. and updated after the markets closed at 1 p.m. PDT to reflect Olaplex’s closing price. The Montecito-based hair care products company Olaplex’s stock began trading on the Nasdaq on Sept. 30, opening at $21 and shooting up to $24.50 by the end of the trading day. Read More →
Olaplex ups IPO price, hopes to raise almost $1.5B
The Montecito-based hair care products company Olaplex upped the projected share price of its planned initial public offering on Sept. 28 and now expects to raise as much as $1.46 billion. Olaplex now plans to price its upcoming IPO at $17 to $19, it said in a filing with the U.S. Securities and Exchange Commission, Read More →
Dubroff: U.S. Bank’s big buy revives long-simmering rivalry with Wells Fargo
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Procore makes its biggest acquisition yet
Procore Technologies announced its first acquisition since going public in May, and it’s the largest one in company history. The Carpinteria-based construction software company said on Sept. 22 that it is purchasing Levelset, a New Orleans-based construction software company, for $500 million: $425 million in cash and $75 million in the form of Procore common Read More →
Amgen wins patent case
Thousand Oaks-based Amgen had a big win in court on Sept. 20, as a federal court in New Jersey upheld multiple Amgen patents for its psoriasis treatment, Otezla. Amgen filed a patent infringement lawsuit earlier this year against two companies, Sandoz and Zydus Pharmaceuticals, claiming that their generic versions of Otezla infringed upon at least Read More →
U.S. Bank’s $8B deal to buy Union Bank could make it region’s biggest banking company
Editor’s Note: This article was originally posted Sept. 21 and updated Sept. 23 with more reporting about the pending bank merger. Union Bank’s 29-branch network in the Tri-Counties will become part of U.S. Bank in an $8 billion deal that will give Union Bank’s Japanese parent a nearly 3% stake in Minneapolis-based U.S. Bancorp. In Read More →
